Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Clariane SE is a leading European operator in the care and support sector for vulnerable individuals, employing 63,000 professionals across six countries and serving 886,000 patients and residents in over 700 cities and communities. The company focuses on three core activities: long-term care homes offering respite stays, day care, and post-hospitalization support; specialty care including medical rehabilitation, mental health services, outpatient hospitalization, and home hospitalization; and community care through shared living solutions, assisted living facilities, personal services, and health and social care. With a 2024 group revenue of €5.282 billion, reflecting 6.6% organic growth, Clariane demonstrates its scale in addressing fragility and vulnerability, guided by values of trust, responsibility, and initiative. Its strategic project 'At your side' emphasizes a shift toward comprehensive care models, innovation in health and longevity, and a CSR roadmap for 2024-2028 centered on five social and environmental commitments. Clariane SE plays a pivotal role in Europe's healthcare landscape, promoting ethical practices, inclusive governance, and purpose-driven operations to enhance quality of life.
Operating margin is thin at 5.35%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue growth slowed to 0.5%, essentially flat. This is a business that needs a catalyst.
Net debt of €6.99B represents 8.6x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
€5.31B
▲ +0.5% YoY
Net Income (TTM)
€9M
▲ +117.8% YoY
Op. Margin
5.35%
ROIC
2.39%
▲ +0.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€816M
▲ +36.0% YoY
Op. Cash Flow (TTM)
€1.07B
▲ +18.1% YoY
Net Debt
€6.99B
Cash & Equiv.
€822M
3Y CAGR: +6.2%
3Y CAGR: +50.5%
Continue Research